K. A. Wojtal, J. J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G. A. Kullak-Ublick and S. R. Vavricka, “Changes in mRNA Expression Levels of Solute Carrier Transporters in In-flammatory Bowel Disease Patients,” Drug Metabolism and Disposition, Vol. 37, No. 9, 2009, pp. 1871-1877. doi:10.1124/dmd.109.027367

has been cited by the following article:

• TITLE: Study on the Expression of Organic Anion Transporting Polypeptide (oatp2a1) in Rat with Spleen Deficiency Syndrome and the Exploration of Clinical Significance

  AUTHORS: Ai-Zhen Pan, Yao-Kun Hao, You-Wu Lin, Ze-Xiong Chen, Shi-Jun Zhang, Xiao Dong, Bin Hu

  KEYWORDS: Dampness, Spleen Deficiency Syndrome, oatp2a1

  JOURNAL NAME: Chinese Medicine, Vol.2 No.3, September 30, 2011

  ABSTRACT: Objective: to explore the mechanism of transportation and transformation of dampness by the way of the expression of organic anion transporting polypeptide (oatp) superfamily member 2a1 (oatp2a1) mRNA in rat with spleen deficiency syndrome and the significance in transportation and transformation of dampness. Methods: 32 wistar male rats were divided randomly into four groups: normal group (n = 6), normal + AA group (n = 6), spleen deficiency group (n = 10), Spleen deficiency + AA group (n = 10). After reserpine-induced spleen deficiency model was made, intragastric administration of aristolochic acid (AA) was adopted for three days, the expression of oatp2a1 mRNA were detected in the tissues of lung, liver, kidney, stomach, small intestine and large intestine in four groups by using Fluorescent Quantitative-Polymerase Chain Reaction (FQ-PCR). Results: the expression of oatp2a1 mRNA in above six tissues could be detected. The ex-pression of oatp2a1 mRNA in liver tissue of rat with spleen deficiency syndrome was up-regulated compared to normal group (P = 0.035, P